Navigation Links
MU celebrates $5 million partnership for advancing biomedical discoveries
Date:8/31/2012

From a tool for treating burn victims to a technique for detecting neurodevelopmental disorders, new products and services for patients are now being developed with support from the University of Missouri's Coulter Translational Partnership Program. Today, the program announced that it is awarding funding to five teams of physicians and engineers who are working together to improve health care.

The new funding is provided by a $5 million partnership between MU and the Wallace H. Coulter Foundation. The partnership establishes MU as one of 15 academic institutions in the country and the only university in Missouri selected to establish a Coulter Translational Partnership Program.

"MU and the Coulter Foundation share a common goal of turning discoveries made in laboratories into new products and services for patients," said MU Chancellor Brady Deaton. "Our investment in translational research involving physicians and engineers at MU builds on the university's substantial resources for advancing biomedical innovation."

MU's Coulter program is awarding funding to five projects that are using biomedical engineering solutions to meet the needs of patients. The projects selected in 2012 involve a total of 10 co-investigators from MU's School of Medicine and College of Engineering. Over the next four years, additional projects will be selected for funding.

"MU is home to a wealth of translational research opportunities waiting to be further developed," said Jinglu Tan, Coulter program principal investigator and James C. Dowell Professor and Chair of Biological Engineering at MU. "Each of the Coulter projects selected for funding demonstrated exceptional scientific merit and potential to meet a well-defined, unmet clinical need."

The five newly funded Coulter projects involve developing better methods for identifying and treating patients with lung cancer, colorectal cancer and other forms of the disease; creating superior grafts for anterior crucial ligament reconstruction surgeries; devising a more accurate way to measure the severity of burn injuries; and inventing a device for earlier detection of neurodevelopmental disorders in infants and toddlers. The projects include collaborations between biological engineers and physicians who specialize in pediatrics, trauma surgery, orthopaedic surgery and pathology.

"Wallace H. Coulter was an engineer, inventor, entrepreneur and visionary who would be pleased by the quality of the translational research occurring at the University of Missouri," said Michael Gara, a Coulter Foundation director. "We look forward to working with MU to further enhance the capacity and pace of biomedical innovation."

In addition to funding, the Coulter program supports scientists by connecting them with research and development experts from private industry and academia. Coulter scientists receive real-world advice on intellectual property protection, regulatory issues and market opportunities. They also engage with potential partners for financing and product development.

"MU's Coulter Translational Partnership Program is designed to help research become attractive for investment and ultimately commercialization," said program director Jake Halliday. "The awards we announced today are designed to bridge the funding gap for promising research projects that have excellent market potential but require more investment to advance through the translational process."

The Coulter program expands on the University of Missouri's many existing resources for translational research. MU is one of the few universities in the nation with schools and colleges of medicine, engineering, nursing, health professions, veterinary medicine, agriculture and business, as well as a nuclear research reactor and comprehensive academic medical center on the same campus. MU's Biodesign and Innovation Program has helped patent new medical technologies by creating teams of students in medicine, engineering and business, and MU's Department of Biological Engineering is a collaboration between the university's engineering college and College of Agriculture, Food and Natural Resources. Mizzou Advantage and its One Health, One Medicine initiative, as well as the MU Institute for Clinical and Translational Science, also invest in turning discoveries into new methods for treating, preventing and managing disease. Several scientists conducting translational research are located in MU's Christopher S. Bond Life Sciences Center.


'/>"/>
Contact: Laura Gerding
gerdingla@health.missouri.edu
573-882-9193
University of Missouri School of Medicine
Source:Eurekalert  

Related biology news :

1. Special issue of the EMBO Journal celebrates 30 years of Wnt research
2. £30 million boost for biomedical engineering research
3. New Nature study illuminates 55 million years of the carbon cycle and climate history
4. Team receives $22.5 million to shed light on the immune system
5. University of Minnesota receives $13.1 million in DOE funding for 2 new nationwide centers
6. WPI receives $1.9 million from US Army to develop sensors that can save wounded soldiers
7. ASU awarded $3 million to research solar energy technologies, launch energy Ph.D. program
8. WaterSMART funds $1.7 million for science projects in desert and southern Rockies LCCs
9. OpenStax Colleges free textbooks will save students $1 million this fall
10. The Johns Hopkins Center for Inherited Disease Research receives $101 million
11. Using millions of years of cell evolution in the fight against cancer
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
MU celebrates $5 million partnership for advancing biomedical discoveries
(Date:11/17/2016)... Global Market Watch: Primarily supported by ownership types; ... Academics) market is to witness a value of US$37.1 billion ... Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from ... 2014-2020. North America is not way ... Europe at 9.56% respectively. Report Focus: ...
(Date:11/15/2016)... ROCKVILLE, Md. , Nov. 15, 2016 /PRNewswire/ ... clinical company developing therapeutics focused on the gut ... public offering of 25,000,000 shares of its common ... its common stock at a price to the ... gross proceeds to Synthetic Biologics from the offering, ...
(Date:11/14/2016)... 14, 2016  Based on its recent ... & Sullivan recognizes FST Biometrics with the ... Visionary Innovation Leadership. FST Biometrics emerged as ... market by pioneering In Motion Identification (IMID) ... seamless, and non-invasive verification. This patented solution ...
Breaking Biology News(10 mins):
(Date:12/2/2016)... ... 2016 , ... Orthogonal, a Chicago-based medical device software company, ... 510(k) clearance for their flagship medical device, SimplECG. , With this FDA approval, ... rely on cloth-based nanosensors. While other companies have attempted to focus on wearable ...
(Date:12/2/2016)... a world leader in rapid infectious disease tests, introduced the Company,s newest product, the ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) Continue Reading ... ... , , bioLytical was invited by the ... INSTI HIV Self Test to 350 pharmacy representatives in Nairobi ...
(Date:11/30/2016)... Fla. , Nov. 30, 2016 Biotest ... products, is pleased to announce the addition of its ... Kearney, Nebraska . The 15,200 square ... on November 29th, 2016 and brings the total number ... Ileana Carlisle , BPC,s Chief Executive Officer ...
(Date:11/30/2016)... , 30. November 2016   ... hat heute die Unterzeichnung einer Reihe von ... zufolge wird Evotec AG Screeningleistungen für Mercks ... bereitstellen. Der Zugriff auf diese Bibliotheken in ... eröffnet einen schnelleren Weg zur Ermittlung und ...
Breaking Biology Technology: